EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor--a novel antibody for immunohistochemistry or AQUA technology.
about
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assaysCholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation-Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma.Epidermal growth factor receptor mutations in nonsmall cell lung carcinoma patients in Kuwait.Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer.EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy.A method for biomarker directed survival prediction in advanced non-small-cell lung cancer patients treated with Carboplatin-based therapy.Expression and clinical value of EGFR in human meningiomas.Tissue microarrays and quantitative tissue-based image analysis as a tool for oncology biomarker and diagnostic development.Application of molecular technologies for phosphoproteomic analysis of clinical samples.Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment.EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.
P2860
Q27852235-0A10CB3B-B7B5-4D2E-88B1-9AAC2D09CCEFQ35631966-51FB3649-EDA7-4CF1-9535-53241B8DC26EQ35710375-E7BC1D76-585B-48C8-A1B8-6E14E48444A1Q36186935-70C03DD2-27B4-4450-89D2-E7A9C98CBEBDQ36662504-93D55AFF-F3CC-45C7-B6C2-F3FF3F129E82Q36821180-84F9FF05-C9BA-4C51-A5F7-B4B7E0184A80Q37204247-E9EEE931-7E6F-4D1F-9EE9-733ABF7D707CQ37384203-95643F47-344A-49D6-8161-F1B7CBE8355DQ37732068-BFDFFD0D-7B6F-4F58-BF4B-765DEB4D9F2DQ38088419-C012B7AB-2A91-407C-833B-FD5613A9DA92Q38194417-0BFD87AA-E50C-466C-A2B1-6E15E665EA79Q38982951-6351CB41-9241-481A-8B56-879D45785198Q39505681-A1FFF1B0-B9F9-4F67-A0D8-D0E2D08E29FBQ42505561-2D03C61B-FC23-4134-AE8C-5DD56B8BDFD2
P2860
EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor--a novel antibody for immunohistochemistry or AQUA technology.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
EGFR protein expression in non ...... ochemistry or AQUA technology.
@ast
EGFR protein expression in non ...... ochemistry or AQUA technology.
@en
type
label
EGFR protein expression in non ...... ochemistry or AQUA technology.
@ast
EGFR protein expression in non ...... ochemistry or AQUA technology.
@en
prefLabel
EGFR protein expression in non ...... ochemistry or AQUA technology.
@ast
EGFR protein expression in non ...... ochemistry or AQUA technology.
@en
P2093
P2860
P1476
EGFR protein expression in non ...... ochemistry or AQUA technology.
@en
P2093
Bernadette Reyna Asuncion
Celine Mascaux
Cindy Tran
Fabien Gaire
Fred R Hirsch
Jason M Zhao
Jim Ranger-Moore
Jun Matsubayashi
Koichi Yoshida
Mark Gustavson
P2860
P304
P356
10.1158/1078-0432.CCR-11-0209
P407
P577
2011-10-12T00:00:00Z